SCHEMBL1127774

SCHEMBL1127774

c1ccc(C[n+]2ccc3ccccc3c2)cc1

nearest known ligand 0.85

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE P22303 13/20 0.85
BCHE P06276 13/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3601825 0.98 ACHE (0.89) ACHEBCHE
Hydrochloric Acid SCHEMBL8870693 0.98 ACHE (0.81) ACHEBCHE
SCHEMBL6767708 0.85 ACHE (0.79) ACHEBCHE
SCHEMBL8870095 0.84 ACHE (0.61) ACHEBCHE
SCHEMBL6771128 0.81 ACHE (0.76) ACHEBCHE
SCHEMBL23259016 0.81 ACHE (0.57) ACHEBCHE
SCHEMBL23258819 0.81 ACHE (0.57) ACHEBCHE
SCHEMBL21750879 0.81 ACHE (0.56) ACHEBCHE
SCHEMBL9565169 0.80 BCHE (0.66) ACHEBCHE
Bromide SCHEMBL23535338 0.79 ACHE (0.60) ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260047777-A1 SYSTEMS AND/OR METHODS FOR ASSESSING NEUROMUSCULAR BLOCK STATUS WITHOUT STIMULATION BLOCKSYNOP INC (US) 2026-02-19 US disclosed
WO-2025096759-A1 SYSTEMS AND/OR METHODS FOR ASSESSING NEUROMUSCULAR BLOCK STATUS WITHOUT STIMULATION BLOCKSYNOP, INC. (US) 2025-05-08 WO disclosed
US-20230174468-A1 SULFATED PILLARARENES, METHODS OF MAKING SAME, AND USES THEREOF UNIVERSITY OF MARYLAND, COLLEGE PARK 2023-06-08 US disclosed
CN-115768745-A Sulfated columnar arenes, methods of making same, and uses thereof 马里兰大学派克分院 2023-03-07 CN disclosed
EP-4110757-A1 SULFATED PILLARARENES, METHODS OF MAKING SAME, AND USES THEREOF University of Maryland, College Park (US) 2023-01-04 EP disclosed
US-20200259085-A1 TREATMENT LIQUID CONTAINING IONIC COMPOUND, ORGANIC ELECTRONIC ELEMENT, AND METHOD FOR PRODUCING ORGANIC ELECTRONIC ELEMENT HITACHI CHEMICAL COMPANY, LTD. 2020-08-13 US disclosed
CN-106939074-B Treatment liquid containing ionic compound 日立化成株式会社 2020-06-16 CN disclosed
US-10665786-B2 Treatment liquid containing ionic compound, organic electronic element, and method for producing organic electronic element HITACHI CHEMICAL COMPANY, LTD. (JP) 2020-05-26 US disclosed
US-20200143954-A1 ORGANIC ELECTRONIC MATERIAL, POLYMERIZATION INITIATOR AND THERMAL POLYMERIZATION INITIATOR, INK COMPOSITION, ORGANIC THIN FILM AND PRODUCTION METHOD FOR SAME, ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, DISPLAY ELEMENT, AND DISPLAY DEVICE HITACHI CHEMICAL COMPANY, LTD. (JP) 2020-05-07 US disclosed
US-20200062783-A1 PHOTO LEWIS ACID GENERATOR NIPPON SHOKUBAI CO., LTD. (JP) 2020-02-27 US disclosed
US-20130037753-A1 ORGANIC ELECTRONIC MATERIAL, POLYMERIZATION INITIATOR AND THERMAL POLYMERIZATION INITIATOR, INK COMPOSITION, ORGANIC THIN FILM AND PRODUCTION METHOD FOR SAME, ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, DISPLAY ELEMENT, AND DISPLAY DEVICE HITACHI CHEMICAL COMPANY, LTD (JP) 2013-02-14 US disclosed
US-8278030-B2 Sulfonium salt, photoacid generator, and photocurable composition and cured body thereof SAN-APRO LIMITED (JP) 2012-10-02 US disclosed
EP-2485290-A1 MATERIAL FOR ORGANIC ELECTRONICS, ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY ELEMENT USING ORGANIC ELECTROLUMINESCENT ELEMENT, ILLUMINATING DEVICE, AND DISPLAY DEVICE Hitachi Chemical Company, Ltd. (JP) 2012-08-08 EP disclosed
US-20120181530-A1 MATERIAL FOR ORGANIC ELECTRONICS, ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY ELEMENT USING ORGANIC ELECTROLUMINESCENT ELEMENT, ILLUMINATING DEVICE, AND DISPLAY DEVICE RESONAC CORPORATION (JP) 2012-07-19 US disclosed
US-20110039205-A1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOCURABLE COMPOSITION AND CURED BODY THEREOF SAN-APRO LIMITED (JP) 2011-02-17 US disclosed
EP-2284165-A1 PHOSPHONIUM SALT, PHOTOACID GENERATOR, PHOTO-CURABLE COMPOSITION, AND CURED PRODUCT OF THE PHOTO-CURABLE COMPOSITION San-Apro Limited (JP) 2011-02-16 EP disclosed
CN-101588803-A Intermediate duration neuromuscular blocking agents and antagonists thereof CORNELL RES FOUNDATION INC WMC (US) 2009-11-25 CN disclosed
US-4235906-A MUSCLE RELAXANTS MASSACHUSETTS GENERAL HOSPITAL (US) 1980-11-25 US disclosed
EP-0010119-A1 Isoquinoline derivatives, their preparation and pharmaceutical compositions containing these compounds THE MASSACHUSETTS GENERAL HOSPITAL (US) 1980-04-30 EP disclosed
US-4192877-A BIS(POLYALKOXYBENZYL)-TETRAHYDROISOQUINOLIUM ALKYL M- OR P- PHENYLENE DIPROPIONATE SALT MASSACHUSETTS GENERAL HOSPITAL (US) 1980-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174468-A1 SULFATED PILLARARENES, METHODS OF MAKING SAME, AND USES THEREOF CD44, SELP, SELPLG ACHE 326/4885BCHE 1515/4885
US-20200062783-A1 PHOTO LEWIS ACID GENERATOR LEO1, LRRK2, LSG1 ACHE 4068/4885BCHE 3567/4885
US-20130037753-A1 ORGANIC ELECTRONIC MATERIAL, POLYMERIZATION INITIATOR AND THERMAL POLYMERIZATION INITIATOR, INK COMPOSITION, ORGANIC THIN FILM AND PRODUCTION METHOD FOR SAME, ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, DISPLAY ELEMENT, AND DISPLAY DEVICE L1CAM, CD99, EPB41L2 ACHE 2657/4885BCHE 3802/4885
US-20110039205-A1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOCURABLE COMPOSITION AND CURED BODY THEREOF ARSA, ASIC1, TST ACHE 4774/4885BCHE 4811/4885
US-20260047777-A1 SYSTEMS AND/OR METHODS FOR ASSESSING NEUROMUSCULAR BLOCK STATUS WITHOUT STIMULATION CHRNB3, CHRNB2, CHRNB4 ACHE 34/4885BCHE 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.